Xeris Biopharma Holdings Inc (XERS)

01:58 AM

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives $6.10 Consensus Target Price from Analysts - Defense World

01:58 AM

May 11, 2025

Xeris Biopharma (NASDAQ:XERS) Stock Price Expected to Rise, Oppenheimer Analyst Says - Defense World

May 11, 2025

May 10, 2025

Xeris Biopharma Holdings First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 10, 2025

May 10, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025

May 10, 2025

Oppenheimer Increases Price Target for Xeris Biopharma (XERS) to $7 | XERS Stock News - GuruFocus

May 10, 2025

May 09, 2025

XERS: Oppenheimer Raises Price Target for Xeris Biopharma Holdings | XERS Stock News - GuruFocus

May 09, 2025

May 09, 2025

Xeris Biopharma: Q1 Earnings Snapshot - New Haven Register

May 09, 2025

May 09, 2025

Xeris Biopharma Reports Record First Quarter 2025 Financial Results - BioSpace

May 09, 2025

May 09, 2025

Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

May 09, 2025

May 09, 2025

Xeris Biopharma Holdings Inc (XERS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements - GuruFocus

May 09, 2025

May 09, 2025

Xeris Biopharma Reports Strong Q1 2025 Growth - TipRanks

May 09, 2025

May 08, 2025

Xeris Pharmaceuticals Reports Strong Earnings and Growth - TipRanks

May 08, 2025

May 08, 2025

Xeris Biopharma raises revenue guidance for 2025 to $260M-$275M amid strong Recorlev growth - MSN

May 08, 2025

May 08, 2025

Xeris Biopharma Holdings, Inc. SEC 10-Q Report - TradingView

May 08, 2025

May 08, 2025

Transcript : Xeris Biopharma Holdings, Inc., Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com

May 08, 2025

May 08, 2025

Market Recap: Xeris Biopharma Holdings Inc (XERS)’s Positive Momentum, Closing at 4.48 - DWinneX

May 08, 2025

May 08, 2025

Xeris Biopharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025

May 08, 2025

Xeris Biopharma (XERS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 08, 2025

May 08, 2025

XERS Revenue Surpasses Expectations with Strong Q1 Performance | XERS Stock News - GuruFocus

May 08, 2025

May 08, 2025

MetLife Investment Management LLC Has $296,000 Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - The AM Reporter

May 08, 2025

May 07, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Bought by Wells Fargo & Company MN - Defense World

May 07, 2025

May 07, 2025

Xeris Pharmaceuticals Q1 2025 Earnings Preview - MSN

May 07, 2025

May 07, 2025

Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings (NASDAQ:XERS) - Seeking Alpha

May 07, 2025

May 05, 2025

Barclays PLC Purchases 23,170 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 05, 2025

May 01, 2025

Xeris Biopharma Holdings Inc [XERS] Records 50-Day SMA of $4.51 - knoxdaily.com

May 01, 2025

May 01, 2025

Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025 - BioSpace

May 01, 2025

May 01, 2025

LPL Financial LLC Decreases Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

May 01, 2025

May 01, 2025

Xeris Biopharma (XERS) Projected to Post Earnings on Thursday - Defense World

May 01, 2025

Apr 30, 2025

Prepare Yourself for Liftoff: Xeris Biopharma Holdings Inc (XERS) - Sete News

Apr 30, 2025

Apr 29, 2025

Market Momentum Report: Xeris Biopharma Holdings Inc (XERS)’s Positive Close at 4.41 - DWinneX

Apr 29, 2025

Apr 29, 2025

Xeris Biopharma Holdings Inc (XERS) stock analysis: A simple moving average approach - uspostnews.com

Apr 29, 2025

Apr 29, 2025

Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long - simplywall.st

Apr 29, 2025

Apr 28, 2025

Recent Insider Activity Suggests Potential Gains for Xeris Biopharma Holdings Inc (XERS) - knoxdaily.com

Apr 28, 2025

Apr 27, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Bought by Russell Investments Group Ltd. - Defense World

Apr 27, 2025

Apr 26, 2025

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit - Yahoo

Apr 26, 2025

Apr 25, 2025

Xeris Biopharma Holdings Inc’s Banking’s 100-Day Moving Average at 3.96: Will the Stock Break Through? - investchronicle.com

Apr 25, 2025

Apr 25, 2025

Xeris Biopharma Holdings Inc (XERS) Performance and Fundamentals Dashboard tells a completely different story - Sete News

Apr 25, 2025

Apr 23, 2025

Understanding the Risks of Investing in Xeris Biopharma Holdings Inc (XERS) - knoxdaily.com

Apr 23, 2025

Apr 23, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 23, 2025

Apr 22, 2025

Is Xeris Biopharma Holdings Inc. (XERS) the Best Multibagger Penny Stock to Buy According to Billionaires? - Insider Monkey

Apr 22, 2025

Apr 22, 2025

10 Best Multibagger Penny Stocks to Buy According to Billionaires - Insider Monkey

Apr 22, 2025

Apr 22, 2025

Are Xeris Biopharma Holdings Inc (XERS) shares a good deal now? - uspostnews.com

Apr 22, 2025

Apr 22, 2025

Market Watch: Xeris Biopharma Holdings Inc (XERS)’s Noteworthy Drop, Closing at 4.02 - DWinneX

Apr 22, 2025

Apr 21, 2025

JPMorgan Chase & Co. Has $3.54 Million Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Apr 21, 2025

Apr 21, 2025

Alliancebernstein L.P. Reduces Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Apr 21, 2025

Apr 17, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Sees Large Growth in Short Interest - Defense World

Apr 17, 2025

Apr 15, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Acquired by Vanguard Group Inc. - Defense World

Apr 15, 2025

Apr 14, 2025

Raymond James Financial Inc. Makes New Investment in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Apr 14, 2025

Apr 13, 2025

Wellington Management Group LLP Sells 6,532 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Apr 13, 2025